In the field of medical investment in the past year, the field of innovative devices has recovered faster than the continued downturn of innovative drugs.
“Six or seven companies have already submitted their IPO declaration forms, and everyone wants to do something big this year.” An insider from an investment institution said this when describing this year’s medical devices, especially innovative medical devices.
Such innovative products are mainly concentrated in the fields of cardiovascular implantation interventional devices, surgical robots, IVD and medical imaging.
The innovation of medical devices has more stable expectations than the innovation of innovative drugs. Although it is also a race against time, device innovation is iterative. Once market share is established through accumulation, it will be difficult to break down barriers.
The innovation of medical devices has more stable expectations than the innovation of innovative drugs. Although it is also a race against time, device innovation is iterative. Once market share is established through accumulation, it will be difficult to break down barriers. But later, the stock price of medical devices fell again and again. The valuations of some innovative medical device companies that were originally promising have been cut in half, and their stocks have even fallen below their net value.
In the field of medical investment in the past year, the field of innovative devices has recovered faster than the continued downturn of innovative drugs.
“Six or seven companies have already submitted their IPO declaration forms, and everyone wants to do something big this year.” An insider from an investment institution said this when describing this year’s medical devices, especially innovative medical devices.
Such innovative products are mainly concentrated in the fields of cardiovascular implantation interventional devices, surgical robots, IVD and medical imaging.
The innovation of medical devices has more stable expectations than the innovation of innovative drugs. Although it is also a race against time, device innovation is iterative. Once market share is established through accumulation, it will be difficult to break down barriers.
The innovation of medical devices has more stable expectations than the innovation of innovative drugs. Although it is also a race against time, device innovation is iterative. Once market share is established through accumulation, it will be difficult to break down barriers. But later, the stock price of medical devices fell again and again. The valuations of some innovative medical device companies that were originally promising have been cut in half, and their stocks have even fallen below their net value.
In fact, the mild trend of centralized purchasing has gradually become clear in September last year. At that time, the Medical Insurance Bureau showed its attitude of supporting and encouraging the development of innovative medical devices. In a reply to the suggestion, it mentioned leaving a certain market aside from centralized bulk procurement to provide space for innovative products to develop the market.
There may be no permanent “safe haven” for collectives. Only by constantly developing more innovative products can we maintain a leading position in this bargain chase war. That is, we need to let the pace of gathering prices not catch up with the pace of innovation.
Nowadays, the east wind of policies is blowing stronger and stronger. For innovative medical devices, centralized procurement has begun to take a gentle path. The window period left for them is right in front of them, and only by continuous innovation can they survive and live long. “In the next 5 to 10 years, with the help of engineer benefits, domestic medical device companies may be able to develop a market value of 300 to 500 billion yuan.”
As one of the manufacturers of CT single injector, CT double head injector, MRI injector, Angiography high pressure injector and consumables, LnkMed also regards innovation as its core competitiveness. We know that only through continuous research and development and improving product performance and quality can we meet the needs of customers and the market and remain invincible in the fierce competition.
Post time: Nov-28-2023
